Jagged 1 Regulates The Proliferation and Metastasis of Human MDA-T68 Thyroid Cancer Cells

Document Type : Original Article


Department of General Surgery, Affiliated Haian Hospital of Nantong University, Haian, China


Objective: The current study evaluated the expression profile and explored the therapeutic implications of Jagged 1
in human thyroid cancer.

Materials and Methods: This experimental study was conducted in 60 paired specimens of papillary thyroid and
adjacent normal tissues. Gene expression was determined by quantitative real time polymerase chain reaction
(qRT-PCR) and western blotting. Transfection of cancer cells was performed by using Lipofectamine 2000. The cell
proliferation of PTC cells was estimated by MTT assay. Clonogenic assay was performed for analysis of colony forming
potential of cancer cells. The apoptosis of PTC cells was studied by using AO/EB and Annexin V-FITC/PI staining
methods. Flow cytometry was done to analyze the cell cycle phase distribution of cancer cells. Migration and invasion
PTC cells were determined respectively with the wound-healing and transwell assays. The impact of Jagged 1 silencing
was investigated in vivo in a xenografted mice model followed by Immunohistochemistry (IHC) analysis.

Results: We found significant (P<0.05) upregulation of Jagged 1 in human thyroid cancer. Silencing of Jagged 1 caused
significant (P<0.05) reduction in proliferation and colony formation of MDA-T68 cells. The inhibitory effects of Jagged
1 silencing were found to be due to the induction of apoptosis. We also found enhancement of Bax and repression of
Bcl-2 protein levels in MDA-T68 cells. Wound healing assay indicated significant (P<0.05) inhibition of cell migration of
MDA-T68 thyroid cancer cells. Additionally, we found that invasion of the thyroid cancer cells was reduced by 55% upon
silencing of Jagged 1. Moreover, Jagged 1 silencing was found to cause inhibition of the Notch intracellular domain
(NICD) and Notch target gene, Hes-1 expression. Finally, Jagged 1 silencing inhibited the xenografted tumors in vivo.

Conclusion: The findings suggest that Jagged 1 regulates the development of thyroid cancer that may act as a
therapeutic target for managing thyroid cancer.


Main Subjects

  1. Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet. 2016; 388(10061): 2783-2795.
  2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1): 7-34.
  3. Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014; 140(4): 317-322.
  4. Iglesias ML, Schmidt A, Ghuzlan AA, Lacroix L, Vathaire F, Chevillard S, et al. Radiation exposure and thyroid cancer: a review. Arch Endocrinol Metab. 2017; 61(2): 180-187.
  5. McLeod DSA, Zhang L, Durante C, Cooper DS. Contemporary debates in adult papillary thyroid cancer management. Endocr Rev. 2019; 40(6): 1481-1499.
  6. Nguyen QT, Lee EJ, Huang MG, Park YI, Khullar A, Plodkowski RA. Diagnosis and treatment of patients with thyroid cancer. Am Health Drug Benefits. 2015; 8(1): 30-40.
  7. Fortini ME. Notch signaling: the core pathway and its posttranslational regulation. Dev Cell. 2009; 16(5): 633-647.
  8. Reedijk M, Odorcic S, Chang L, Zhang H, Miller N, McCready DR, et al. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res. 2005; 65(18): 8530-8537.
  9. Kim HJ, Kim MJ, Kim A, Jung CW, Park S, Koh JS, et al. The role of Notch1 signaling in anaplastic thyroid carcinoma. Cancer Res Treat. 2017; 49(2): 509-517.
  10. Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009; 137(2): 216-233.
  11. Wilson A, Radtke F. Multiple functions of Notch signaling in self-renewing organs and cancer. FEBS Lett. 2006; 580(12): 2860-2868.
  12. Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol. 2006; 7(9): 678-689.
  13. Santagata S, Demichelis F, Riva A, Varambally S, Hofer MD, Kutok JL, et al. JAGGED1 expression is associated with prostate cancer metastasis and recurrence. Cancer Res. 2004; 64(19): 6854-6857.
  14. Steg AD, Katre AA, Goodman B, Han HD, Nick AM, Stone RL, et al. Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer. Clin Cancer Res. 2011; 17(17): 5674- 5685.
  15. Wu DM, Wang S, Wen X, Han XR, Wang YJ, Shen M, et al. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma. Cell Death Dis. 2018; 9(10): 947.
  16. Nikiforov YE, Carty SE, Chiosea SI, Coyne C, Duvvuri U, Ferris RL, et al. Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay. Cancer. 2014; 120(23): 3627-3634.
  17. Guilmeau S. Notch signaling and intestinal cancer. Adv Exp Med Biol. 2012; 727: 272-288.
  18. Choi JH, Park JT, Davidson B, Morin PJ, Shih IeM, Wang TL. Jagged- 1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion. Cancer Res. 2008; 68(14): 5716-5723.
  19. Sethi N, Dai X, Winter CG, Kang Y. Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell. 2011; 19(2): 192-205.
  20. Purow BW, Haque RM, Noel MW, Su Q, Burdick MJ, Lee J, et al. Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res. 2005; 65(6): 2353-2363.
  21. Lin JT, Chen MK, Yeh KT, Chang CS, Chang TH, Lin CY, et al. Association of high levels of Jagged-1 and Notch-1 expression with poor prognosis in head and neck cancer. Ann Surg Oncol. 2010; 17(11): 2976-2983.
  22. Gao J, Liu J, Fan D, Xu H, Xiong Y, Wang Y, et al. Up-regulated expression of Notch1 and Jagged1 in human colon adenocarcinoma. Pathol Biol (Paris). 2011; 59(6): 298-302.
  23. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis. 2000; 21(3): 485-495.
  24. Zeeshan R, Mutahir Z. Cancer metastasis - tricks of the trade. Bosn J Basic Med Sci. 2017; 17(3): 172-182. 25. Sjölund J, Manetopoulos C, Stockhausen MT, Axelson H. The notch pathway in cancer: differentiation gone awry. Eur J Cancer. 2005; 41(17): 2620-2629.
  25. Chen W, Cao G, Yuan X, Zhang X, Zhang Q, Zhu Y, et al. Notch-1 knockdown suppresses proliferation, migration and metastasis of salivary adenoid cystic carcinoma cells. J Transl Med. 2015; 13: 167.
  26. Hrabĕ de Angelis M, McIntyre J 2nd, Gossler A. Maintenance of somite borders in mice requires the Delta homologue DII1. Nature. 1997; 386(6626): 717-721.
  27. Xue Y, Gao X, Lindsell CE, Norton CR, Chang B, Hicks C, et al. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet. 1999; 8(5): 723-730.